InMed Pharmaceuticals Inc (INM)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
7,581,400
EV to revenue ratio (TTM)
0.456
EV to ebitda
0.506
Financial Performance
Revenue (TTM)
4,942,600
Gross profit (TTM)
1,706,600
EBITDA
-9,689,845
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-66.50%
Return on equity (TTM)
-156.80%
Per Share Metrics
Revenue per share (TTM)
1.47
EPS
-2.84
Diluted EPS (TTM)
-2.84
Book value
0.2
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
0.891
Price to book ratio (TTM)
7.05
Growth
Quarterly earnings growth (YoY)
-26.20%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
0.978